Abstract POSTER-THER-1418: PD-1 mediated paralysis of ovarian cancer infiltrating dendritic cells
Lavakumar Karyampudi(Mayo Clinic), Keith L. Knutson(WinnMed), Ellen L. Goode(Mayo Clinic in Arizona), Kimberly R. Kalli(Mayo Clinic), James Krempski(University of North Carolina at Chapel Hill), Karen E. Hedin(Unknown), Purushottam Lamichhane(Mayo Clinic), Doris M. Vargas(Mayo Clinic), Marshall D. Behrens(Mayo Clinic), Lynn C. Hartmann(Mayo Clinic)
Cited by 0
Related Papers
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
|JNCI Journal of the National Cancer Institute|2015|441
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
|The Lancet Oncology|2013|434